Global Puerarin Injection Market Growth 2026-2032

August 2026 | 92 pages | ID: G5E695DB6585EN
LP Information

Abstracts

The global Puerarin Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Puerarin Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Puerarin Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Puerarin Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Puerarin Injection players cover Medisan, Tianjin Tianyao Pharmaceutical, Youcare Pharmaceutical Group, Tiantai Mountain Pharmaceutical, China Res Double-Crane, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Puerarin Injection Industry Forecast? looks at past sales and reviews total world Puerarin Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Puerarin Injection sales for 2026 through 2032. With Puerarin Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Puerarin Injection industry.

This Insight Report provides a comprehensive analysis of the global Puerarin Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Puerarin Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Puerarin Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Puerarin Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Puerarin Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Puerarin Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 50mg/1ml
• 100mg/2ml

Segmentation by Application:

• Hospital
• Clinic

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Medisan
• Tianjin Tianyao Pharmaceutical
• Youcare Pharmaceutical Group
• Tiantai Mountain Pharmaceutical
• China Res Double-Crane
• Actiza Pharmaceutical

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Puerarin Injection market?
• What factors are driving Puerarin Injection market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Puerarin Injection market opportunities vary by end market size?
• How does Puerarin Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Puerarin Injection Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Puerarin Injection by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Puerarin Injection by Country/Region, 2021, 2025 & 2032
2.2 Puerarin Injection Segment by Type
  2.2.1 50mg/1ml
  2.2.2 100mg/2ml
  2.2.3 Puerarin Injection Sales by Type
    2.2.3.1 Global Puerarin Injection Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Puerarin Injection Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Puerarin Injection Sale Price by Type (2021-2026)
2.3 Puerarin Injection Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Puerarin Injection Sales by Application
    2.3.3.1 Global Puerarin Injection Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Puerarin Injection Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Puerarin Injection Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Puerarin Injection Breakdown Data by Company
  3.1.1 Global Puerarin Injection Annual Sales by Company (2021-2026)
  3.1.2 Global Puerarin Injection Sales Market Share by Company (2021-2026)
3.2 Global Puerarin Injection Annual Revenue by Company (2021-2026)
  3.2.1 Global Puerarin Injection Revenue by Company (2021-2026)
  3.2.2 Global Puerarin Injection Revenue Market Share by Company (2021-2026)
3.3 Global Puerarin Injection Sale Price by Company
3.4 Key Manufacturers Puerarin Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Puerarin Injection Product Location Distribution
  3.4.2 Players Puerarin Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PUERARIN INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Puerarin Injection Market Size by Geographic Region (2021-2026)
  4.1.1 Global Puerarin Injection Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Puerarin Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Puerarin Injection Market Size by Country/Region (2021-2026)
  4.2.1 Global Puerarin Injection Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Puerarin Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Puerarin Injection Sales Growth
4.4 APAC Puerarin Injection Sales Growth
4.5 Europe Puerarin Injection Sales Growth
4.6 Middle East & Africa Puerarin Injection Sales Growth

5 AMERICAS

5.1 Americas Puerarin Injection Sales by Country
  5.1.1 Americas Puerarin Injection Sales by Country (2021-2026)
  5.1.2 Americas Puerarin Injection Revenue by Country (2021-2026)
5.2 Americas Puerarin Injection Sales by Type (2021-2026)
5.3 Americas Puerarin Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Puerarin Injection Sales by Region
  6.1.1 APAC Puerarin Injection Sales by Region (2021-2026)
  6.1.2 APAC Puerarin Injection Revenue by Region (2021-2026)
6.2 APAC Puerarin Injection Sales by Type (2021-2026)
6.3 APAC Puerarin Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Puerarin Injection by Country
  7.1.1 Europe Puerarin Injection Sales by Country (2021-2026)
  7.1.2 Europe Puerarin Injection Revenue by Country (2021-2026)
7.2 Europe Puerarin Injection Sales by Type (2021-2026)
7.3 Europe Puerarin Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Puerarin Injection by Country
  8.1.1 Middle East & Africa Puerarin Injection Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Puerarin Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Puerarin Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Puerarin Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Puerarin Injection
10.3 Manufacturing Process Analysis of Puerarin Injection
10.4 Industry Chain Structure of Puerarin Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Puerarin Injection Distributors
11.3 Puerarin Injection Customer

12 WORLD FORECAST REVIEW FOR PUERARIN INJECTION BY GEOGRAPHIC REGION

12.1 Global Puerarin Injection Market Size Forecast by Region
  12.1.1 Global Puerarin Injection Forecast by Region (2027-2032)
  12.1.2 Global Puerarin Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Puerarin Injection Forecast by Type (2027-2032)
12.7 Global Puerarin Injection Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Medisan
  13.1.1 Medisan Company Information
  13.1.2 Medisan Puerarin Injection Product Portfolios and Specifications
  13.1.3 Medisan Puerarin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Medisan Main Business Overview
  13.1.5 Medisan Latest Developments
13.2 Tianjin Tianyao Pharmaceutical
  13.2.1 Tianjin Tianyao Pharmaceutical Company Information
  13.2.2 Tianjin Tianyao Pharmaceutical Puerarin Injection Product Portfolios and Specifications
  13.2.3 Tianjin Tianyao Pharmaceutical Puerarin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Tianjin Tianyao Pharmaceutical Main Business Overview
  13.2.5 Tianjin Tianyao Pharmaceutical Latest Developments
13.3 Youcare Pharmaceutical Group
  13.3.1 Youcare Pharmaceutical Group Company Information
  13.3.2 Youcare Pharmaceutical Group Puerarin Injection Product Portfolios and Specifications
  13.3.3 Youcare Pharmaceutical Group Puerarin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Youcare Pharmaceutical Group Main Business Overview
  13.3.5 Youcare Pharmaceutical Group Latest Developments
13.4 Tiantai Mountain Pharmaceutical
  13.4.1 Tiantai Mountain Pharmaceutical Company Information
  13.4.2 Tiantai Mountain Pharmaceutical Puerarin Injection Product Portfolios and Specifications
  13.4.3 Tiantai Mountain Pharmaceutical Puerarin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Tiantai Mountain Pharmaceutical Main Business Overview
  13.4.5 Tiantai Mountain Pharmaceutical Latest Developments
13.5 China Res Double-Crane
  13.5.1 China Res Double-Crane Company Information
  13.5.2 China Res Double-Crane Puerarin Injection Product Portfolios and Specifications
  13.5.3 China Res Double-Crane Puerarin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 China Res Double-Crane Main Business Overview
  13.5.5 China Res Double-Crane Latest Developments
13.6 Actiza Pharmaceutical
  13.6.1 Actiza Pharmaceutical Company Information
  13.6.2 Actiza Pharmaceutical Puerarin Injection Product Portfolios and Specifications
  13.6.3 Actiza Pharmaceutical Puerarin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Actiza Pharmaceutical Main Business Overview
  13.6.5 Actiza Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Puerarin Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Puerarin Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 50mg/1ml
Table 4. Major Players of 100mg/2ml
Table 5. Global Puerarin Injection Sales by Type (2021-2026) & (M Units)
Table 6. Global Puerarin Injection Sales Market Share by Type (2021-2026)
Table 7. Global Puerarin Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Puerarin Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Puerarin Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Puerarin Injection Sale by Application (2021-2026) & (M Units)
Table 11. Global Puerarin Injection Sale Market Share by Application (2021-2026)
Table 12. Global Puerarin Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Puerarin Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Puerarin Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Puerarin Injection Sales by Company (2021-2026) & (M Units)
Table 16. Global Puerarin Injection Sales Market Share by Company (2021-2026)
Table 17. Global Puerarin Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Puerarin Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Puerarin Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Puerarin Injection Producing Area Distribution and Sales Area
Table 21. Players Puerarin Injection Products Offered
Table 22. Puerarin Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Puerarin Injection Sales by Geographic Region (2021-2026) & (M Units)
Table 26. Global Puerarin Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Puerarin Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Puerarin Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Puerarin Injection Sales by Country/Region (2021-2026) & (M Units)
Table 30. Global Puerarin Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Puerarin Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Puerarin Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Puerarin Injection Sales by Country (2021-2026) & (M Units)
Table 34. Americas Puerarin Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Puerarin Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Puerarin Injection Sales by Type (2021-2026) & (M Units)
Table 37. Americas Puerarin Injection Sales by Application (2021-2026) & (M Units)
Table 38. APAC Puerarin Injection Sales by Region (2021-2026) & (M Units)
Table 39. APAC Puerarin Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Puerarin Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Puerarin Injection Sales by Type (2021-2026) & (M Units)
Table 42. APAC Puerarin Injection Sales by Application (2021-2026) & (M Units)
Table 43. Europe Puerarin Injection Sales by Country (2021-2026) & (M Units)
Table 44. Europe Puerarin Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Puerarin Injection Sales by Type (2021-2026) & (M Units)
Table 46. Europe Puerarin Injection Sales by Application (2021-2026) & (M Units)
Table 47. Middle East & Africa Puerarin Injection Sales by Country (2021-2026) & (M Units)
Table 48. Middle East & Africa Puerarin Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Puerarin Injection Sales by Type (2021-2026) & (M Units)
Table 50. Middle East & Africa Puerarin Injection Sales by Application (2021-2026) & (M Units)
Table 51. Key Market Drivers & Growth Opportunities of Puerarin Injection
Table 52. Key Market Challenges & Risks of Puerarin Injection
Table 53. Key Industry Trends of Puerarin Injection
Table 54. Puerarin Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Puerarin Injection Distributors List
Table 57. Puerarin Injection Customer List
Table 58. Global Puerarin Injection Sales Forecast by Region (2027-2032) & (M Units)
Table 59. Global Puerarin Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Puerarin Injection Sales Forecast by Country (2027-2032) & (M Units)
Table 61. Americas Puerarin Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Puerarin Injection Sales Forecast by Region (2027-2032) & (M Units)
Table 63. APAC Puerarin Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Puerarin Injection Sales Forecast by Country (2027-2032) & (M Units)
Table 65. Europe Puerarin Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Puerarin Injection Sales Forecast by Country (2027-2032) & (M Units)
Table 67. Middle East & Africa Puerarin Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Puerarin Injection Sales Forecast by Type (2027-2032) & (M Units)
Table 69. Global Puerarin Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Puerarin Injection Sales Forecast by Application (2027-2032) & (M Units)
Table 71. Global Puerarin Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Medisan Basic Information, Puerarin Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Medisan Puerarin Injection Product Portfolios and Specifications
Table 74. Medisan Puerarin Injection Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Medisan Main Business
Table 76. Medisan Latest Developments
Table 77. Tianjin Tianyao Pharmaceutical Basic Information, Puerarin Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Tianjin Tianyao Pharmaceutical Puerarin Injection Product Portfolios and Specifications
Table 79. Tianjin Tianyao Pharmaceutical Puerarin Injection Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Tianjin Tianyao Pharmaceutical Main Business
Table 81. Tianjin Tianyao Pharmaceutical Latest Developments
Table 82. Youcare Pharmaceutical Group Basic Information, Puerarin Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Youcare Pharmaceutical Group Puerarin Injection Product Portfolios and Specifications
Table 84. Youcare Pharmaceutical Group Puerarin Injection Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Youcare Pharmaceutical Group Main Business
Table 86. Youcare Pharmaceutical Group Latest Developments
Table 87. Tiantai Mountain Pharmaceutical Basic Information, Puerarin Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Tiantai Mountain Pharmaceutical Puerarin Injection Product Portfolios and Specifications
Table 89. Tiantai Mountain Pharmaceutical Puerarin Injection Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Tiantai Mountain Pharmaceutical Main Business
Table 91. Tiantai Mountain Pharmaceutical Latest Developments
Table 92. China Res Double-Crane Basic Information, Puerarin Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. China Res Double-Crane Puerarin Injection Product Portfolios and Specifications
Table 94. China Res Double-Crane Puerarin Injection Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. China Res Double-Crane Main Business
Table 96. China Res Double-Crane Latest Developments
Table 97. Actiza Pharmaceutical Basic Information, Puerarin Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Actiza Pharmaceutical Puerarin Injection Product Portfolios and Specifications
Table 99. Actiza Pharmaceutical Puerarin Injection Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Actiza Pharmaceutical Main Business
Table 101. Actiza Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Puerarin Injection
Figure 2. Puerarin Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Puerarin Injection Sales Growth Rate 2021-2032 (M Units)
Figure 7. Global Puerarin Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Puerarin Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Puerarin Injection Sales Market Share by Country/Region (2025)
Figure 10. Puerarin Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 50mg/1ml
Figure 12. Product Picture of 100mg/2ml
Figure 13. Global Puerarin Injection Sales Market Share by Type in 2026
Figure 14. Global Puerarin Injection Revenue Market Share by Type (2021-2026)
Figure 15. Puerarin Injection Consumed in Hospital
Figure 16. Global Puerarin Injection Market: Hospital (2021-2026) & (M Units)
Figure 17. Puerarin Injection Consumed in Clinic
Figure 18. Global Puerarin Injection Market: Clinic (2021-2026) & (M Units)
Figure 19. Global Puerarin Injection Sale Market Share by Application (2025)
Figure 20. Global Puerarin Injection Revenue Market Share by Application in 2026
Figure 21. Puerarin Injection Sales by Company in 2026 (M Units)
Figure 22. Global Puerarin Injection Sales Market Share by Company in 2026
Figure 23. Puerarin Injection Revenue by Company in 2026 ($ millions)
Figure 24. Global Puerarin Injection Revenue Market Share by Company in 2026
Figure 25. Global Puerarin Injection Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Puerarin Injection Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Puerarin Injection Sales 2021-2026 (M Units)
Figure 28. Americas Puerarin Injection Revenue 2021-2026 ($ millions)
Figure 29. APAC Puerarin Injection Sales 2021-2026 (M Units)
Figure 30. APAC Puerarin Injection Revenue 2021-2026 ($ millions)
Figure 31. Europe Puerarin Injection Sales 2021-2026 (M Units)
Figure 32. Europe Puerarin Injection Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Puerarin Injection Sales 2021-2026 (M Units)
Figure 34. Middle East & Africa Puerarin Injection Revenue 2021-2026 ($ millions)
Figure 35. Americas Puerarin Injection Sales Market Share by Country in 2026
Figure 36. Americas Puerarin Injection Revenue Market Share by Country (2021-2026)
Figure 37. Americas Puerarin Injection Sales Market Share by Type (2021-2026)
Figure 38. Americas Puerarin Injection Sales Market Share by Application (2021-2026)
Figure 39. United States Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Puerarin Injection Sales Market Share by Region in 2026
Figure 44. APAC Puerarin Injection Revenue Market Share by Region (2021-2026)
Figure 45. APAC Puerarin Injection Sales Market Share by Type (2021-2026)
Figure 46. APAC Puerarin Injection Sales Market Share by Application (2021-2026)
Figure 47. China Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. India Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Puerarin Injection Sales Market Share by Country in 2026
Figure 55. Europe Puerarin Injection Revenue Market Share by Country (2021-2026)
Figure 56. Europe Puerarin Injection Sales Market Share by Type (2021-2026)
Figure 57. Europe Puerarin Injection Sales Market Share by Application (2021-2026)
Figure 58. Germany Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 59. France Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Puerarin Injection Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Puerarin Injection Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Puerarin Injection Sales Market Share by Application (2021-2026)
Figure 66. Egypt Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Puerarin Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Puerarin Injection in 2026
Figure 72. Manufacturing Process Analysis of Puerarin Injection
Figure 73. Industry Chain Structure of Puerarin Injection
Figure 74. Channels of Distribution
Figure 75. Global Puerarin Injection Sales Market Forecast by Region (2027-2032)
Figure 76. Global Puerarin Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Puerarin Injection Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Puerarin Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Puerarin Injection Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Puerarin Injection Revenue Market Share Forecast by Application (2027-2032)